Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma
- PMID: 31046067
- PMCID: PMC6499123
- DOI: 10.1001/jamaophthalmol.2019.0900
Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma
Retraction in
-
Notice of Retraction and Replacement. Kang et al. Association of statin use and high serum cholesterol levels with risk of primary open-angle glaucoma. JAMA Ophthalmol. 2019;137(7):756-765.JAMA Ophthalmol. 2020 May 1;138(5):588-589. doi: 10.1001/jamaophthalmol.2020.0027. JAMA Ophthalmol. 2020. PMID: 32163112 No abstract available.
Abstract
Importance: The use of statins (hydroxymethylglutaryl coenzyme A inhibitors) has been associated with a lower risk of primary open-angle glaucoma (POAG); however, results have been conflicting, and little is known about the association between high cholesterol levels and POAG.
Objective: To assess the association of elevated cholesterol levels and statin use with incident POAG.
Design, setting, and participants: This study used data collected biennially from participants aged 40 years or older who were free of glaucoma and reported eye examinations, within 3 population-based cohorts: the Nurses' Health Study (N = 50 710; followed up from 2000 to 2014), the Nurses' Health Study 2 (N = 62 992; 1999-2015), and the Health Professionals Follow-up Study (N = 23 080; 2000-2014). Incident cases of POAG were confirmed by medical record review. The analyses were performed in January 2019.
Exposures: Biennially updated self-reported information on elevated cholesterol level status, serum cholesterol levels, and duration of statin use.
Main outcomes and measures: Multivariable-adjusted relative risks (RRs) and 95% CIs were estimated using Cox proportional hazards regression models on pooled data, with stratification by cohort.
Results: Among the 136 782 participants in the 3 cohorts (113 702 women and 23 080 men), 886 incident cases of POAG were identified. Every 20-mg/dL increase in total serum cholesterol was associated with a 7% increase in risk of POAG (RR, 1.07 [95% CI, 1.02-1.11]; P = .004). Any self-reported history of elevated cholesterol was also associated with a higher risk of POAG (RR, 1.17 [95% CI, 1.00-1.37]). A history of any statin use was associated with a 15% lower risk of POAG (RR, 0.85 [95% CI, 0.73-0.99]). Use of statins for 5 or more years vs never use of statins was associated with a 21% lower risk of POAG (RR, 0.79 [95% CI, 0.65-0.97]; P = .02 for linear trend). The association between use of statins for 5 or more years vs never use of statins and risk of POAG was more inverse in those who were older (≥65 years: RR, 0.70 [95% CI, 0.56-0.87] vs <65 years: RR, 1.05 [95% CI, 0.68-1.63]; P = .01 for interaction).
Conclusions and relevance: Among adults aged 40 years or older, higher serum cholesterol levels were associated with higher risk of POAG, while 5 or more years of statin use compared with never use of statins was associated with a lower risk of POAG.
Conflict of interest statement
Figures
Comment in
-
The Role of Statins and Cholesterol in the Primary Prevention of Primary Open-Angle Glaucoma.JAMA Ophthalmol. 2019 Jul 1;137(7):765-766. doi: 10.1001/jamaophthalmol.2019.0860. JAMA Ophthalmol. 2019. PMID: 31046110 Free PMC article. No abstract available.
Similar articles
-
Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up Study.JAMA Ophthalmol. 2016 Mar;134(3):294-303. doi: 10.1001/jamaophthalmol.2015.5601. JAMA Ophthalmol. 2016. PMID: 26767881 Free PMC article.
-
Prospective study of flavonoid intake and risk of primary open-angle glaucoma.Acta Ophthalmol. 2018 Sep;96(6):e692-e700. doi: 10.1111/aos.13705. Epub 2018 Mar 14. Acta Ophthalmol. 2018. PMID: 29536641 Free PMC article.
-
Anthropometric measures and their relation to incident primary open-angle glaucoma.Ophthalmology. 2010 Aug;117(8):1521-9. doi: 10.1016/j.ophtha.2009.12.017. Epub 2010 Apr 10. Ophthalmology. 2010. PMID: 20382429 Free PMC article.
-
Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2016 Nov 15;316(19):2008-2024. doi: 10.1001/jama.2015.15629. JAMA. 2016. PMID: 27838722 Review.
-
Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review.JAMA. 2013 May 15;309(19):2035-42. doi: 10.1001/jama.2013.5099. JAMA. 2013. PMID: 23677315 Review.
Cited by
-
Associations of different types of statins with the risk of open-angle glaucoma: a systematic review and network meta-analysis.Graefes Arch Clin Exp Ophthalmol. 2024 Aug 30. doi: 10.1007/s00417-024-06620-9. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39212799
-
Profile of Lipoprotein Subclasses in Chinese Primary Open-Angle Glaucoma Patients.Int J Mol Sci. 2024 Apr 21;25(8):4544. doi: 10.3390/ijms25084544. Int J Mol Sci. 2024. PMID: 38674129 Free PMC article.
-
Association between statin use and open-angle glaucoma: a nested case-control study using the Japanese claims database.Sci Rep. 2023 Jul 19;13(1):11677. doi: 10.1038/s41598-023-38957-2. Sci Rep. 2023. PMID: 37468563 Free PMC article.
-
Software development skills for health data researchers.BMJ Health Care Inform. 2022 Aug;29(1):e100488. doi: 10.1136/bmjhci-2021-100488. BMJ Health Care Inform. 2022. PMID: 35944928 Free PMC article. No abstract available.
-
Statins Inhibit the Gliosis of MIO-M1, a Müller Glial Cell Line Induced by TRPV4 Activation.Int J Mol Sci. 2022 May 6;23(9):5190. doi: 10.3390/ijms23095190. Int J Mol Sci. 2022. PMID: 35563594 Free PMC article.
References
-
- US Preventive Services Task Force Statin use for the primary prevention of cardiovascular disease in adults: recommendation statement. Am Fam Physician. 2017;95(2). - PubMed
-
- Downs JR, Clearfield M, Weis S, et al. . Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS: Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279(20):1615-1622. doi:10.1001/jama.279.20.1615 - DOI - PubMed
-
- Sillesen H, Amarenco P, Hennerici MG, et al. ; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators . Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008;39(12):3297-3302. doi:10.1161/STROKEAHA.108.516450 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
